Glemser is a global IT solutions provider for life science organizations, aiming to enhance patient outcomes. Since 1987, Glemser has been offering software and advisory services to regulated industries, assisting clients in integrating emerging technologies and innovative methods to tackle crucial business needs. This, in turn, enables companies to more effectively develop and market medications, ultimately leading to improved patient outcomes. In particular, Glemser is revolutionizing global product labeling with ComplianceAuthor AI, a solution that significantly reduces the time needed to produce a submission-ready label. This GxP compliance structured content authoring system not only saves time but also enhances quality and ensures sustained compliance. Drawing on their extensive experience in implementing large-scale IT solutions for global companies, Glemser excels in executing and validating content and quality management solutions that evolve along with their clients' changing cultures and systems.
There is no investment information
No recent news or press coverage available for Glemser.